A client taking enoxaparin (Lovenox) daily indicates which statement requires additional monitoring?

• A. I take aspirin daily for headaches.
• B. I take ibuprofen (Motrin) at least once a week for joint pain.
• C. Whenever I have a fever, I take acetaminophen (Tylenol).
• D. I take my medicine first thing in the morning.

Answer: (A)

Combining an anticoagulant with an antiplatelet agent raises the risk of bleeding, so a statement about daily aspirin use with enoxaparin needs closer clinical monitoring. Enoxaparin (a low‑molecular‑weight heparin) dampens clot formation by inhibiting coagulation factors, while aspirin irreversibly inhibits platelet function to prevent aggregation. Together, these effects compound the tendency to bleed, making it essential to watch closely for signs of hemorrhage—unexplained bruising, gum or nosebleeds, blood in stool or urine, or unusual fatigue from possible anemia. Routine LMWH monitoring isn’t typically required, but with daily aspirin the clinician may increase surveillance or adjust therapy based on bleeding risk. The other statements don’t carry the same ongoing bleeding risk: acetaminophen doesn’t affect platelets; an occasional NSAID like ibuprofen carries some risk but not the same persistent antiplatelet effect as daily aspirin; and taking the morning dose doesn’t add a specific monitoring need beyond general safety.